164 related articles for article (PubMed ID: 8235928)
1. Treatment of uncomplicated gonorrhea with single doses of 200 mg cefixime.
Verdon MS; Douglas JM; Wiggins SD; Handsfield HH
Sex Transm Dis; 1993; 20(5):290-3. PubMed ID: 8235928
[TBL] [Abstract][Full Text] [Related]
2. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group.
Handsfield HH; McCormack WM; Hook EW; Douglas JM; Covino JM; Verdon MS; Reichart CA; Ehret JM
N Engl J Med; 1991 Nov; 325(19):1337-41. PubMed ID: 1922235
[TBL] [Abstract][Full Text] [Related]
3. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections.
Portilla I; Lutz B; Montalvo M; Mogabgab WJ
Sex Transm Dis; 1992; 19(2):94-8. PubMed ID: 1534422
[TBL] [Abstract][Full Text] [Related]
4. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA
J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431
[TBL] [Abstract][Full Text] [Related]
5. Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group.
Hook EW; McCormack WM; Martin D; Jones RB; Bean K; Maroli AN
Antimicrob Agents Chemother; 1997 Aug; 41(8):1843-5. PubMed ID: 9257777
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a single 400 mg oral dose of cefixime in the treatment of uncomplicated gonorrhea.
Kuhlwein A; Nies BA
Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):261-2. PubMed ID: 2496996
[No Abstract] [Full Text] [Related]
7. Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary.
Echols RM; Heyd A; O'Keeffe BJ; Schacht P
Sex Transm Dis; 1994; 21(6):345-52. PubMed ID: 7871449
[TBL] [Abstract][Full Text] [Related]
8. Cefixime in the treatment of uncomplicated gonorrhea.
Dunnett DM; Moyer MA
Sex Transm Dis; 1992; 19(2):92-3. PubMed ID: 1595018
[TBL] [Abstract][Full Text] [Related]
9. A Phase 1 Pharmacokinetic and Safety Study of Extended-Duration, High-dose Cefixime for Cephalosporin-resistant Neisseria gonorrhoeae in the Pharynx.
Barbee LA; Nayak SU; Blumer JL; OʼRiordan MA; Gray W; Zenilman JM; Golden MR; Griffiss JM
Sex Transm Dis; 2018 Oct; 45(10):677-683. PubMed ID: 29624558
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea.
McCormack WM; Mogabgab WJ; Jones RB; Hook EW; Wendel GD; Handsfield HH
Sex Transm Dis; 1993; 20(5):269-73. PubMed ID: 8235924
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women.
Collier AC; Judson FN; Murphy VL; Leach LA; Root CJ; Handsfield HH
Am J Med; 1984 Oct; 77(4C):68-72. PubMed ID: 6093523
[TBL] [Abstract][Full Text] [Related]
12. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval.
Deguchi T; Yasuda M; Yokoi S; Ishida K; Ito M; Ishihara S; Minamidate K; Harada Y; Tei K; Kojima K; Tamaki M; Maeda S
J Infect Chemother; 2003 Mar; 9(1):35-9. PubMed ID: 12673405
[TBL] [Abstract][Full Text] [Related]
13. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
[TBL] [Abstract][Full Text] [Related]
14. Treatment of uncomplicated gonorrhea with cefotaxime.
Handsfield HH
Rev Infect Dis; 1982; 4 Suppl():S448-52. PubMed ID: 6294798
[TBL] [Abstract][Full Text] [Related]
15. Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection.
Matsumoto T; Muratani T; Takahashi K; Ikuyama T; Yokoo D; Ando Y; Sato Y; Kurashima M; Shimokawa H; Yanai S
J Infect Chemother; 2006 Jun; 12(3):145-7. PubMed ID: 16826347
[TBL] [Abstract][Full Text] [Related]
16. Time required for elimination of Neisseria gonorrhoeae from the urogenital tract in men with symptomatic urethritis: comparison of oral and intramuscular single-dose therapy.
Haizlip J; Isbey SF; Hamilton HA; Jerse AE; Leone PA; Davis RH; Cohen MS
Sex Transm Dis; 1995; 22(3):145-8. PubMed ID: 7652655
[TBL] [Abstract][Full Text] [Related]
17. Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
Taylor SN; Marrazzo J; Batteiger BE; Hook EW; Seña AC; Long J; Wierzbicki MR; Kwak H; Johnson SM; Lawrence K; Mueller J
N Engl J Med; 2018 Nov; 379(19):1835-1845. PubMed ID: 30403954
[TBL] [Abstract][Full Text] [Related]
18. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.
Allen VG; Mitterni L; Seah C; Rebbapragada A; Martin IE; Lee C; Siebert H; Towns L; Melano RG; Low DE
JAMA; 2013 Jan; 309(2):163-70. PubMed ID: 23299608
[TBL] [Abstract][Full Text] [Related]
19. [Cefixime therapy in patients with proven gonorrhea].
Backhaus A; Tinzl J
Infection; 1990; 18 Suppl 3():S145-6. PubMed ID: 2079375
[TBL] [Abstract][Full Text] [Related]
20. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
